Third-Party Tested ≥98% HPLC Purity — USA Shipped

GH Secretagogues Research Guide

GHRP-6: Mechanism, Handling & Research Guide

Also known as: GHRP-6, GHRP6, Growth Hormone Releasing Peptide-6, GHRP-6 acetate, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2, SKF-110679, CAS 87616-84-0

Key Facts

GHRP-6 is a gh secretagogues research peptide (C46H56N12O6, MW 873.03 g/mol). Synthetic hexapeptide ghrelin receptor agonist for GH release research. It is supplied as a lyophilized powder for laboratory and in-vitro research use only — not for human consumption.

Classification Synthetic hexapeptide ghrelin receptor (GHS-R1a) agonist / growth hormone secretagogue
Molecular Formula C46H56N12O6
Molecular Weight 873.03 g/mol
CAS Number 87616-84-0
Research Half-Life Approximately 15-60 minutes in published pharmacokinetic characterizations (short-acting; exact value varies by model)
Form Lyophilized powder
Research Category GH Secretagogues

What is GHRP-6?

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that functions as a potent ghrelin receptor (GHS-R1a) agonist, stimulating the anterior pituitary to release growth hormone in a pulsatile manner. Its mechanism involves both direct pituitary stimulation and hypothalamic amplification through GHRH neurons, producing robust GH elevations that mimic natural secretory patterns. Research published in the Journal of Endocrinology demonstrated that GHRP-6 use in animal models produced significant GH release within 15-30 minutes, with peak levels 5-10 times above baseline. Studies by Bowers et al. (1991) were among the first to characterize its GH-releasing potency. Notably, research in Neuroscience Letters has indicated neuroprotective properties in ischemic brain injury models, where GHRP-6 reduced infarct volume and improved neurological outcomes through anti-apoptotic pathways. Compared to other GH secretagogues like Ipamorelin and GHRP-2, GHRP-6 produces the strongest appetite-stimulating effect due to its ghrelin-mimetic activity. It also raises cortisol and prolactin to a greater degree than Ipamorelin, making it less selective but more potent in overall GH output. GHRP-2 shares similar potency but with slightly reduced hunger effects. For storage, lyophilized GHRP-6 should be kept at -20C for long-term preservation. Once reconstituted with bacteriostatic water, store at 2-8C and use within 4 weeks. This peptide is widely studied by endocrinologists, neuroscientists investigating ischemia-reperfusion injury, and researchers examining growth hormone physiology and appetite regulation pathways.

GHRP-6 Research Applications

In published and preclinical research, GHRP-6 has been studied across the following areas:

  • Cognition and synaptic-plasticity research
  • Neuroprotection in ischemia models
  • Collagen-synthesis and ECM research
  • Cardiovascular protection research

GHRP-6 in Research: Study Context

Published literature characterizes GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) as one of the original growth hormone-releasing peptides, acting on the ghrelin receptor GHS-R1a to evoke pulsatile GH release through complementary hypothalamic and pituitary sites, with documented synergy when co-used with GHRH (Bowers et al.). For laboratory research, the lyophilized peptide is reconstituted with bacteriostatic water to a defined concentration such as 10.0 mg/mL (10 mg vial in 1 mL) and refrigerated at 2-8C. This product is sold for in-vitro and laboratory research use only, is not FDA-approved, and carries no human concentration; investigators should reference the primary literature and document each lot's Certificate of Analysis (COA) for identity and purity.

How GHRP-6 Compares

Researchers frequently evaluate GHRP-6 alongside related compounds:

  • GHRP-6 vs Ipamorelin — Selective GHS-R1a agonist with minimal cortisol/prolactin/appetite effects, versus GHRP-6's broader ghrelin-pathway activation
  • GHRP-6 vs Hexarelin Acetate — More potent, metabolically stabilized hexapeptide secretagogue with additional CD36-mediated cardiac signaling not seen with GHRP-6
  • GHRP-6 vs Sermorelin Acetate — Acts on the GHRH receptor rather than the ghrelin receptor - the complementary, synergistic pathway to GHRP-6

GHRP-6 — Frequently Asked Questions

What receptor does GHRP-6 act on in published studies?
In the primary literature GHRP-6 is characterized as an agonist of the growth hormone secretagogue receptor (GHS-R1a, the ghrelin receptor). Bowers and colleagues demonstrated GH release through a dual, complementary action at hypothalamic and pituitary sites distinct from the GHRH receptor pathway.
How is GHRP-6 prepared for in-vitro research?
The lyophilized hexapeptide is reconstituted with bacteriostatic water to a defined concentration for laboratory use - for example 10.0 mg/mL for a 10 mg vial reconstituted in 1 mL. Bacteriostatic water is added slowly along the vial wall, the solution is not shaken, and it is stored at 2-8C. This is a research-use-only handling procedure, not a instruction.
How does GHRP-6 differ from ipamorelin in the literature?
Comparative characterizations describe GHRP-6 as a potent but less selective secretagogue that also activates ghrelin-mediated appetite signaling and can raise cortisol and prolactin, whereas ipamorelin is reported as a highly selective GH secretagogue with minimal effect on those other pituitary hormones. Researchers select GHRP-6 when ghrelin-pathway or appetite signaling is part of the model.
Is GHRP-6 approved for human use?
No. GHRP-6 is not an FDA-approved drug. It is supplied strictly for in-vitro and laboratory research use only, and the published record concerns experimental pharmacology rather than any therapeutic indication. Each research lot should ship with a Certificate of Analysis documenting purity and identity.
Is GHRP-6 legal to buy for research?
GHRP-6 is sold in the United States as a research chemical for laboratory and in-vitro use only. It is not approved by the FDA for human use and is not sold for human consumption. Researchers are responsible for compliance with all applicable federal, state, and institutional regulations.
Does GHRP-6 come with a Certificate of Analysis?
Yes. Every batch of GHRP-6 from Elyte Peptides ships with a third-party Certificate of Analysis (COA) documenting identity and HPLC purity (≥98%), so research results can be traced to a verified lot.
What is GHRP-6 Acetate and how does it work?
GHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) that functions as an agonist of the ghrelin receptor (GHS-R1a). It stimulates GH release from the pituitary and also triggers appetite through ghrelin signaling. GHRP-6 acts synergistically with GHRH — when used together, GH output is amplified beyond what either compound produces alone.
What research has been done on GHRP-6?
Published research in Neuropeptides demonstrated GHRP-6's neuroprotective effects in cerebral ischemia models, reducing infarct volume and inflammatory markers. Studies in the Journal of Endocrinology showed robust GH secretion with concentration-dependent cortisol and prolactin effects. Additional research has explored GHRP-6's role in wound healing (collagen deposition acceleration), hepatoprotection, and cardiovascular protection through GH-independent mechanisms.
How does GHRP-6 compare to Ipamorelin?
GHRP-6 is a potent but less selective GH secretagogue compared to ipamorelin. GHRP-6 significantly increases appetite (via ghrelin receptor activation), cortisol, and prolactin, while ipamorelin releases GH with minimal effects on these parameters. Researchers choose GHRP-6 when studying ghrelin pathway interactions or when appetite stimulation is relevant to the research model, and ipamorelin when clean GH-specific data is needed.

Research References

  1. Bowers CY, Reynolds GA, Durham D, et al. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 1990.
  2. Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984.
All research guides